(Q34794627)

4 August 2017

1 reference

title

Receptor-mediated hepatocarcinogenesis: role of hepatocyte proliferation and apoptosis (English)

1 reference

4 August 2017

Jason D Oliver

1

1 reference

PubMed ID

12193254

4 August 2017

Ruth A Roberts

series ordinal

2

1 reference

4 August 2017

1 July 2002

1 reference

Basic and Clinical Pharmacology and Toxicology

4 August 2017

1 reference

4 August 2017

91

1 reference

4 August 2017

1

1 reference

4 August 2017

1-7

1 reference

Too many rodent carcinogens: mitogenesis increases mutagenesis

4 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Post-translational modifications and activation of p53 by genotoxic stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Inhibition of apoptosis in rat hepatocytes treated with 'non-dioxin-like' polychlorinated biphenyls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Liver toxicity and apoptosis: role of TGF-beta1, cytochrome c and the apoptosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Protein kinase C signaling and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

The search for molecular mechanisms of non-genotoxic carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

The perturbation of apoptosis and mitosis by drugs and xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Long-term hazards of polychlorinated dibenzodioxins and polychlorinated dibenzofurans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Comparative effects of dieldrin on hepatic ploidy, cell proliferation, and apoptosis in rodent liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Epigenetic mechanisms of chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

The role of oxidative stress in chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: A quantitative analysis of experimental data using a stochastic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

A comparison of liver tumor diagnoses from seven PCB studies in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Induction of cytochrome P-450 in the Norway rat, Rattus norvegicus, following exposure to potential environmental contaminants

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

21 January 2018

Bcl-2 family proteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Peroxisome proliferator-activated receptors in tumorigenesis: targets of tumour promotion and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Regulation and function of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Molecular biology of the Ah receptor and its role in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Ah receptor ligands and tumor promotion: survival of neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Monograph: reassessment of human cancer risk of aldrin/dieldrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

7 January 2021

Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

7 January 2021

Inhibition of gap-junctional-intercellular communication in intact rat liver by nongenotoxic hepatocarcinogens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

7 January 2021

Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.910101.X

7 January 2021

10.1034/J.1600-0773.2002.910101.X

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12193254